191 related articles for article (PubMed ID: 23475713)
1. N-glycosylation humanization for production of therapeutic recombinant glycoproteins in Saccharomyces cerevisiae.
Arico C; Bonnet C; Javaud C
Methods Mol Biol; 2013; 988():45-57. PubMed ID: 23475713
[TBL] [Abstract][Full Text] [Related]
2. A dual approach for improving homogeneity of a human-type N-glycan structure in Saccharomyces cerevisiae.
Piirainen MA; Boer H; de Ruijter JC; Frey AD
Glycoconj J; 2016 Apr; 33(2):189-99. PubMed ID: 26983412
[TBL] [Abstract][Full Text] [Related]
3. Production of complex human glycoproteins in yeast.
Hamilton SR; Bobrowicz P; Bobrowicz B; Davidson RC; Li H; Mitchell T; Nett JH; Rausch S; Stadheim TA; Wischnewski H; Wildt S; Gerngross TU
Science; 2003 Aug; 301(5637):1244-6. PubMed ID: 12947202
[TBL] [Abstract][Full Text] [Related]
4. Engineering of a mammalian O-glycosylation pathway in the yeast Saccharomyces cerevisiae: production of O-fucosylated epidermal growth factor domains.
Chigira Y; Oka T; Okajima T; Jigami Y
Glycobiology; 2008 Apr; 18(4):303-14. PubMed ID: 18252777
[TBL] [Abstract][Full Text] [Related]
5. [Construction of the Man8 GlcNAc2 glycosylation Saccharomyces cerevisiae mutant strain].
Zhou JG; Zhang HC; Wang P; Qi QS
Wei Sheng Wu Xue Bao; 2007 Oct; 47(5):785-9. PubMed ID: 18062249
[TBL] [Abstract][Full Text] [Related]
6. Deglycosylation systematically improves N-glycoprotein identification in liquid chromatography-tandem mass spectrometry proteomics for analysis of cell wall stress responses in Saccharomyces cerevisiae lacking Alg3p.
Bailey UM; Schulz BL
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Apr; 923-924():16-21. PubMed ID: 23454304
[TBL] [Abstract][Full Text] [Related]
7. Identification of alg3 in the mushroom-forming fungus Schizophyllum commune and analysis of the Δalg3 knockout mutant.
Berends E; Lehle L; Henquet M; Hesselink T; Wösten HA; Lugones LG; Bosch D
Glycobiology; 2013 Feb; 23(2):147-54. PubMed ID: 22997240
[TBL] [Abstract][Full Text] [Related]
8. Development of valuable yeast strains using a novel mutagenesis technique for the effective production of therapeutic glycoproteins.
Abe H; Takaoka Y; Chiba Y; Sato N; Ohgiya S; Itadani A; Hirashima M; Shimoda C; Jigami Y; Nakayama K
Glycobiology; 2009 Apr; 19(4):428-36. PubMed ID: 19129247
[TBL] [Abstract][Full Text] [Related]
9. Disruption of the OCH1 and MNN1 genes decrease N-glycosylation on glycoprotein expressed in Kluyveromyces lactis.
Liu B; Gong X; Chang S; Yang Y; Song M; Duan D; Wang L; Ma Q; Wu J
J Biotechnol; 2009 Aug; 143(2):95-102. PubMed ID: 19559061
[TBL] [Abstract][Full Text] [Related]
10. The KTR and MNN1 mannosyltransferase families of Saccharomyces cerevisiae.
Lussier M; Sdicu AM; Bussey H
Biochim Biophys Acta; 1999 Jan; 1426(2):323-34. PubMed ID: 9878809
[TBL] [Abstract][Full Text] [Related]
11. Engineering of the yeast Yarrowia lipolytica for the production of glycoproteins lacking the outer-chain mannose residues of N-glycans.
Song Y; Choi MH; Park JN; Kim MW; Kim EJ; Kang HA; Kim JY
Appl Environ Microbiol; 2007 Jul; 73(14):4446-54. PubMed ID: 17513593
[TBL] [Abstract][Full Text] [Related]
12. Expression and purification of recombinant M-Pol I from Saccharomyces cerevisiae with alpha-1,6 mannosylpolymerase activity.
Rodionov D; Romero PA; Berghuis AM; Herscovics A
Protein Expr Purif; 2009 Jul; 66(1):1-6. PubMed ID: 19249370
[TBL] [Abstract][Full Text] [Related]
13. Engineering yeast for producing human glycoproteins: where are we now?
Laukens B; De Visscher C; Callewaert N
Future Microbiol; 2015; 10(1):21-34. PubMed ID: 25598335
[TBL] [Abstract][Full Text] [Related]
14. Recombinant protein production in yeasts.
Mattanovich D; Branduardi P; Dato L; Gasser B; Sauer M; Porro D
Methods Mol Biol; 2012; 824():329-58. PubMed ID: 22160907
[TBL] [Abstract][Full Text] [Related]
15. N-hypermannose glycosylation disruption enhances recombinant protein production by regulating secretory pathway and cell wall integrity in Saccharomyces cerevisiae.
Tang H; Wang S; Wang J; Song M; Xu M; Zhang M; Shen Y; Hou J; Bao X
Sci Rep; 2016 May; 6():25654. PubMed ID: 27156860
[TBL] [Abstract][Full Text] [Related]
16. Production of humanized glycoproteins in bacteria and yeasts.
Chiba Y; Jigami Y
Curr Opin Chem Biol; 2007 Dec; 11(6):670-6. PubMed ID: 17936668
[TBL] [Abstract][Full Text] [Related]
17. [Pichia pastoris X-33 with OCH1 gene deletion and its expression of glycoprotein GM-CSF].
Zhang D; Xu Y; Xin X; Zhu R; Jin J
Wei Sheng Wu Xue Bao; 2011 May; 51(5):622-9. PubMed ID: 21800624
[TBL] [Abstract][Full Text] [Related]
18. Abolishment of N-glycan mannosylphosphorylation in glyco-engineered Saccharomyces cerevisiae by double disruption of MNN4 and MNN14 genes.
Kim YH; Kang JY; Gil JY; Kim SY; Shin KK; Kang HA; Kim JY; Kwon O; Oh DB
Appl Microbiol Biotechnol; 2017 Apr; 101(7):2979-2989. PubMed ID: 28101612
[TBL] [Abstract][Full Text] [Related]
19. Disruption of the MNN10 gene enhances protein secretion in Kluyveromyces lactis and Saccharomyces cerevisiae.
Bartkeviciūte D; Sasnauskas K
FEMS Yeast Res; 2004 Sep; 4(8):833-40. PubMed ID: 15450190
[TBL] [Abstract][Full Text] [Related]
20. Engineering the baculovirus genome to produce galactosylated antibodies in lepidopteran cells.
Juliant S; Lévêque M; Cérutti P; Ozil A; Choblet S; Violet ML; Slomianny MC; Harduin-Lepers A; Cérutti M
Methods Mol Biol; 2013; 988():59-77. PubMed ID: 23475714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
